Liraglutide injection

Liraglutide injection

Form: Pre filled Pen

Strength: 6 mg/mL

Reference Brands: Saxenda®(US & EU)

Category: Diabetes

Saxenda® (liraglutide 3 mg), a GLP-1 receptor agonist, is FDA-approved for chronic weight management in adults (BMI ≥30 or ≥27 with comorbidities) and adolescents (12+). The EMA approves it for adults only, with similar BMI criteria. Both regulators mandate a boxed warning for thyroid C-cell tumor risk and contraindicate use in patients with personal/family history of MTC or MEN 2. Discontinue if <5% weight loss occurs after 12 weeks. Storage: Refrigerate (2–8°C); stable at ≤30°C (USA) or ≤25°C (EU) post-opening. Platforms like Pharmatradz.com streamline global B2B access to compliant Saxenda® sourcing and licensing.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength: U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details Get Enquiry
Insulin Lispro (Humalog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details Get Enquiry
Insulin Aspart (Novolog) injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details Get Enquiry
Insulin Glargine (Lantus) injectable

Strength: U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.